MGC Pharmaceuticals

King of the Hill – THC Global Receives "Most Significant" Cannabis License in Australia

THC Global Limited (ASX:THC) announced game changing news this week, after the company revealed that it has been granted the "most significant cannabis Manufacture license in Austr...

Knock Out – CWEB Punches Through with CBD Gummies and Strong Q1 Results

The market leader in hemp CBD extract products, Charlotte's Web Holdings (TSX:CWEB), had a blockbuster week after it officially unveiled its newest CBD product line—hemp extract-...

Pushing the Limits – Valens Scales Up Extraction Capacity and Receives TSXV Listing Approval

This week the spotlight shined on Valens GroWorks Corp (CSE: VGW)—a multi-licensed, vertically integrated provider of cannabis products and services—after the company announced...

Bowling a Double – Canopy Growth Corporation Strikes Again

It's been a milestone week for Canopy Growth Corporation (TSX:WEED), after the company announced that it had received a new licence from Health Canada permitting it to grow cannabi...

6 Additional Aussie cannabis stocks to watch in 2019 – cannpal, botanix, thc asx and more!

Should you buy shares in thc asx? What about eve investments or mgc pharma? Read on to find out more.The Australian cannabis market is gearing up for a groundbreaking 2019. Last ye...

MGC Pharma Secures Sale & Distribution Agreement for ArtemiC

MGC Pharma has signed a Binding Term Sheet with K.S. KIM International Ltd, a wholly-owned division of SK-Pharma Group, for the sales and distribution of ArtemiC in Israel, Russia,...

MGC Pharma Releases Formidable Half-Yearly Interim Financial Report

The company hit a number of key milestones during this period, including material prescription increases and entry into multiple new international markets. There was more big news...

MGC Pharma Lights Up the Market with Update on Brazilian Distribution Deal

The company sent its share price climbing by 8.00% following the release of a market update on its Brazilian distribution deal with ONIX Empreendimentos e Participações. The Euro...

No Love For Pot Stocks in February

As if the cannabis industry had not been beaten up enough, along came a Chuck Norris style virus that has imploded the global markets.The Global Cannabis Index (as managed by New C...

MGC Pharma Kicks Off CogniCann Phase II Trials with First Australian Patients

The company has officially launched Phase II clinical trials for its dementia and Alzheimer's drug, following the receipt of its first bulk shipment of CogniCann in December 2019Th...